Plans to resume domestic inspections could keep FDA on track with PDUFA timelines

Despite the pandemic, FDA is on track for a banner year for new drug approvals, and its plan to gradually resume domestic inspections starting the week of July 20 could help keep it on track in the second half.

Read the full 398 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers